In Vivo
>>Business Strategy

BTG SP Makes A Virtue Of Manufacturing And Supply Discipline Despite COVID

Risk Minimization Strategy Paid Off For BTG Specialty Pharma, Which Recently Became Part Of The SERB Group

01 Apr 2021

Manufacturing and supply chain resilience ensured that BTG Specialty Pharma met its sales target in the COVID-affected 2020. Its president, Anthony Higham, explained how this was possible while the company busily ̶ and quietly – sought new ownership, and all under the shadow of Brexit.

IV2103 FAb Fragment Antibodies Antivenom Production

No noise and no drama. It is a precept that has been keenly respected by the staff and management of BTG Specialty Pharma over the past few years, much to the pride of its president, Anthony Higham.

In November 2018, Boston Scientific Corporation announced the $4.2bn purchase of UK group BTG plc, which had built...